Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors
- 9 August 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 65 (5) , 655-659
Abstract
Summary: Objective We aimed to assess whether metabolic abnormalities can explain endothelial dysfunction and associated cardiovascular disease risk (CVDr) in polycystic ovary syndrome (PCOS). Endothelial function, a recognized composite marker of CVDr, may be reduced in PCOS and can be precisely and noninvasively assessed by cardiovascular magnetic resonance (CMR).Patients Fourteen women with anovulatory PCOS (age [mean ± SD] 33 ± 4 years) and 13 controls (age: 33 ± 6 years) with similar body mass index and regular menses.Methods Endothelium‐dependent (flow‐mediated dilatation – FMD) and ‐independent (glyceryl trinitrate – GTN) changes in the brachial artery area were measured using CMR in women with PCOS and controls. Arterial function was assessed twice, in the early follicular phase and mid cycle in controls and after an interval of 2 weeks in PCOS subjects. Fasting lipids, glucose, insulin and sex hormones were measured at the first visit.Results FMD was greatly reduced in women with PCOS compared to controls (−1%vs 5% and 2%vs 12%, P < 0·01) without differences in GTN responses. Risk factors were more prevalent in PCOS women and displayed significant linear relationships with FMD. PCOS status was the strongest predictor of FMD. Linear regression between PCOS and FMD remained significant after correction for all CVD risk markers linked to the metabolic syndrome.Conclusion PCOS is associated with changes in CVD risk markers and pronounced endothelial dysfunction. However endothelial dysfunction with PCOS is only partly explained by recognized CVD risk markers.Keywords
This publication has 32 references indexed in Scilit:
- Polycystic Ovary SyndromeNew England Journal of Medicine, 2005
- Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndromeThrombosis Research, 2005
- Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular EventsCirculation, 2003
- Long-Term Use of Contraceptive Depot Medroxyprogesterone Acetate in Young Women Impairs Arterial Endothelial Function Assessed by Cardiovascular Magnetic ResonanceCirculation, 2002
- Variation within the Type 2 Diabetes Susceptibility Gene Calpain-10 and Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2002
- Menstrual Cycle Irregularity and Risk for Future Cardiovascular DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2002
- Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial FunctionCirculation, 2002
- Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin TherapyThe Journal of Clinical Endocrinology & Metabolism, 2001
- Normal Endothelial Function Despite Insulin Resistance in Healthy Women with the Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2000
- Dyslipidaemia is associated with insulin resistance in women with polycystic ovariesClinical Endocrinology, 1996